Moderna Looks To Catch Up In COVID-19 For Kids, While Still Branching Out In Other Areas

Biotech Teases Non-COVID Respiratory Programs

The company hopes to expand Spikevax’s reach beyond the current approved population while also looking to take the lead in mRNA vaccines in other diseases.

Moderna announced data from the Phase II/III KidCOVE study of Spikevax • Source: Alamy

More from COVID-19

More from Scrip